시장보고서

상품코드

1571635

주사 약물전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 치료 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Injectable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Therapeutic Use, By End-use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 09월 | 리서치사:

Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

주사 약물전달 기기 시장 성장 및 동향:

Grand View Research, Inc.의 최신 보고서에 따르면, 세계 주사제 전달 장치 시장 규모는 2030년까지 8,232억 9,000만 달러에 달할 것으로 예상됩니다.

이 시장은 2024년부터 2030년까지 연평균 8.7%의 성장률을 보일 것으로 예상됩니다. 당뇨병, 암과 같은 만성 질환의 증가로 인해 주사를 통한 약물전달의 필요성이 증가하고 있습니다. 다른 전통적인 약물전달 형태와 달리 주사제는 첫 번째 통과 대사를 우회하기 때문에 약물의 생체 이용률을 극대화할 수 있습니다. 기술이 발전함에 따라, 제조 및 판매되는 장치는 환자의 특정 요구를 충족시키기 위해 제작 및 판매되고 있습니다.

자가주사 기기의 출현으로 의료 보조 없이도 주사제를 스스로 투여할 수 있게 되었습니다. 바이오의약품 시장에서 많은 기술 지향적 인 개척이 이루어지고 있으며, 도전적인 질병 영역에서 이러한 주사기구의 적용 가능성을 더욱 높이고 있습니다. 자가 주사기를 통해 당뇨병 환자는 자동 주사기, 펜형 주사기, 바늘이 없는 주사기를 사용하여 인슐린 농도를 관리할 수 있게 되었습니다.

이 시장의 주요 억제요인은 주사바늘로 인한 부상 및 감염, 규제 상환에 대한 모호성, 주사제의 무균성, 독성이 낮고 투여가 용이한 다른 약물전달 시스템에 대한 선호도입니다. 이러한 시장 억제요인에도 불구하고 대부분의 주요 업체들이 다른 전달 형태보다 주사제를 선택하고 있으며, 주사제 전달 제품의 시장 잠재력은 매우 큽니다. 주사제 전달 산업은 제품 유형에 따라 자가 주사 장치와 기존 주사 장치의 두 가지 하위 유형으로 나뉩니다. 또한, 치료 용도에 따라 주사제 전달 산업은 자가면역질환, 호르몬 질환, 종양학 및 기타로 구분됩니다.

최종사용자 용도별로 주사제 전달 산업은 병원, 재택 간호 환경, 연구 시설, 진단 및 임상 실험실을 포함한 기타로 분류됩니다.

주사 약물전달 기기 시장 보고서 하이라이트

예측 기간 동안 종양학 분야는 9.3%의 가장 빠른 CAGR을 기록할 것으로 예상됩니다. 이는 전 세계 암 발병률의 증가와 표적 치료의 발전으로 인한 것입니다.
2023년 시장 점유율은 병원이 53.2%로 압도적일 것으로 예상됩니다. 병원에서는 빠른 치료 효과를 제공할 수 있는 첨단 주사기 채택이 증가하고 있으며, 이는 응급 의료 및 위기 상황에서 매우 중요합니다.
북미 약물전달 기기 시장은 2023년 40.5%의 점유율을 차지할 것으로 예상됩니다. 북미는 당뇨병, 암, 자가면역질환 등 만성질환을 앓고 있는 인구가 많습니다.

주사 약물전달 기기 시장 점유율, 지역별, 2023년 및 2030년
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아태평양
- 중국
- 일본
- 인도
- 한국
- 호주
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 상황

주요 시장 진출 기업의 최근 동향과 영향 분석
기업 분류
기업 히트맵 분석
기업 개요
- Baxter
- Schott AG
- BD
- Eli Lilly and Company
- Terumo Corporation
- Elcam Medical
- Unilife Corporation
- Ypsomed AG
- Gerresheimer AG
- Sanofi

ksm 24.11.01

Injectable Drug Delivery Devices Market Growth & Trends:

The global injectable drug delivery devices market size is anticipated to reach USD 823.29 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 8.7% from 2024 to 2030. The increase in the number of chronic diseases like diabetes and cancer has fueled the need for injectable drug delivery. Unlike other traditional forms of drug delivery, injectables allow maximum bioavailability of the pharmaceutical drug as it bypasses the first-pass metabolism. With substantial growth in technological advancements, the devices being manufactured and marketed are built so as to cater to the specific needs of the patients.

With the advent of self-injection devices, injectable drugs can be self-administered without the need for medical assistance. A large number of technology-oriented developments have taken place in the biologics market, which further increases the applicability of these injectable devices in the challenging disease areas. Self-injection devices have allowed patients suffering from diabetes to manage insulin levels with auto-injectors, pen-injectors, and needle-free injectors; thus, the homecare segment has been a large grosser in the end-user application.

The major restraints in this market are injuries and infections caused by needles, ambiguities related to regulatory reimbursements, sterility of the injectable drugs, and the preference of other drug delivery systems that possess less toxicity and are easy to administer. Despite these restraints, the market potential for injectable drug delivery products is tremendous with the majority of the key players opting to injectables over other forms of delivery. The injectable drug delivery industry, based on product type is segmented into two sub-types namely self-injection devices and conventional injection devices. Further, on the basis of therapeutic use, the injectable drug delivery industry is segmented into autoimmune disorders, hormonal disorders, oncology, and others.

The injectable drug delivery industry by end-user application is categorized into hospitals, home care settings, and others including research establishments, diagnostics, and clinical laboratories.

Injectable Drug Delivery Devices Market Report Highlights:

Oncology is anticipated to witness the fastest CAGR of 9.3% over the forecast period. This is due to the growing incidence of cancer globally and the evolution of targeted therapies.
Hospitals dominated the market with 53.2% share in 2023. Hospitals are increasingly adopting advanced injectable devices due to their ability to provide rapid therapeutic effects, which is crucial in emergency care and critical situations.
North America injectable drug delivery devices market dominated with 40.5% market share in 2023. North America has a significant population with chronic diseases such as diabetes, cancer, and autoimmune disorders.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Injectable Drug Delivery Devices Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Injectable Drug Delivery Devices Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Injectable Drug Delivery Devices Market: Product Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Injectable Drug Delivery Devices Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.3. Devices
- 4.3.1. Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.2. Self-injection Devices
  - 4.3.2.1. Self-injection Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.3.3. Conventional Devices
  - 4.3.3.1. Conventional Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Formulations
- 4.4.1. Formulations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.2. Conventional Drug Delivery
  - 4.4.2.1. Conventional Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.3. Novel Drug Delivery
  - 4.4.3.1. Novel Drug Delivery Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.4.4. Others
  - 4.4.4.1. Others Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Injectable Drug Delivery Devices Market: Therapeutic Use Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Injectable Drug Delivery Devices Market: Therapeutic Use Movement Analysis, 2023 & 2030 (USD Million)
5.3. Autoimmune Disorders
- 5.3.1. Autoimmune Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Hormonal Disorders
- 5.4.1. Hormonal Disorders Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Oncology
- 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Injectable Drug Delivery Devices Market: End Use Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Injectable Drug Delivery Devices Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospitals
- 6.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Homecare Settings
- 6.4.1. Homecare Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Others
- 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Injectable Drug Delivery Devices Market: Regional Estimates & Trend Analysis

7.1. Injectable Drug Delivery Devices Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. UK Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. China
  - 7.4.2.1. China Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. Japan
  - 7.4.3.1. Japan Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. South Korea
  - 7.4.5.1. South Korea Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. Australia
  - 7.4.6.1. Australia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. UAE Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Injectable Drug Delivery Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Baxter
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Schott AG
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. BD
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Eli Lilly and Company
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Terumo Corporation
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Elcam Medical
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. Unilife Corporation
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Ypsomed AG
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Gerresheimer AG
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives
- 8.4.10. Sanofi
  - 8.4.10.1. Participant's Overview
  - 8.4.10.2. Financial Performance
  - 8.4.10.3. Product Benchmarking
  - 8.4.10.4. Recent Developments/ Strategic Initiatives

주사 약물전달 기기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 치료 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Injectable Drug Delivery Devices Market Size, Share & Trends Analysis Report By Product, By Therapeutic Use, By End-use, By Region, And Segment Forecasts, 2024 - 2030

주사 약물전달 기기 시장 성장 및 동향:

주사 약물전달 기기 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 주사 약물전달 기기 시장 변수, 동향, 범위

제4장 주사 약물전달 기기 시장 : 제품 추정·동향 분석

제5장 주사 약물전달 기기 시장 : 치료 용도 추정·동향 분석

제6장 주사 약물전달 기기 시장 : 최종 용도 추정·동향 분석

제7장 주사 약물전달 기기 시장 : 지역 추정·동향 분석